Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Collagen patch put to the test: will it irritate skin?

NCT ID NCT07473661

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study tested whether a collagen-based material causes skin irritation or allergic reactions. Thirteen healthy adults wore patches with the material on their skin repeatedly. Researchers checked for redness, swelling, or other signs of irritation using a standard grading scale. The goal was to see if the material is safe for future use in medical or cosmetic products.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
collagen-based material
What this could lead to
If the material is shown to be safe on skin, it could be used in future medical products like wound dressings or cosmetic patches.
What could go wrong
This was a very small safety study with only 13 healthy volunteers. It does not test effectiveness for any disease, and results may not apply to people with skin conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

13 people

The number who actually took part.

Started

Feb 2026

Finished

May 2026

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 70 years * Male and female participants * Fitzpatrick Skin Types I and VI * Participants of any race * Participants of any ethnicity (Hispanic or Latino or Not Hispanic or Latino) * Generally healthy, without dermatological or systemic conditions that could interfere with study participation or evaluation of results, as determined by the investigator * Able to read and understand English and provide written informed consent * Able to comply with study procedures and complete all required visits * Willing to have test materials applied according to the study protocol * Has not participated in a similar clinical study within the previous 30 days * Agrees to avoid excessive sun exposure, sunbathing, or tanning during study participation * Female participants of childbearing potential willing to undergo pregnancy testing prior to participation * Agrees not to change current personal care products during study participation Exclusion Criteria: * Use of medications that may interfere with study results (e.g., corticosteroids, antihistamines, immunosuppressive agents, or high-dose NSAIDs) * History of acute or chronic medical conditions that could interfere with study participation or increase risk (e.g., autoimmune disease, HIV infection) * Chronic skin conditions such as atopic dermatitis or eczema * Treatment for skin cancer within the previous 12 months * Abnormal or damaged skin at test sites that could interfere with evaluation (e.g., sunburn, tattoos, scars, active dermatologic conditions) * Diabetes requiring insulin therapy * Pregnant, planning pregnancy, or breastfeeding * Known hypersensitivity to personal care products, cosmetics, fragrances, or adhesives * Known fish allergy * Any condition that, in the opinion of the investigator, may compromise participant safety or study integrity

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SerenaGroup Monroeville

    Monroeville, Pennsylvania, 15146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.